Concepedia

Ryo Hanajiri

RH

14

Publications

769

Citations

13

H-Index

2014

Active since

Affiliations

Nagoya University(Current)

Children's National

George Washington University

Nagoya City University

Tokyo Metropolitan Komagome Hospital

Ryo Hanajiri is an author at Nagoya University specializing in immunotherapy, immunology, and medicine.

ORCID

Top concepts

Publications per year

2014–2024

14

Publications

14

Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells

Keisuke Watanabe, Seitaro Terakura, Anton C. Martens et al. · The Journal of Immunology · 2014 · 280 citations

A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration

Reona Sakemura, Seitaro Terakura, Keisuke Watanabe et al. · Cancer Immunology Research · 2016 · 164 citations · Full text

, , +16

Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study

Amy B Hont, Carolina Colli Cruz, Robert Ulrey et al. · Journal of Clinical Oncology · 2019 · 74 citations · Full text

Risk factors for <scp>CAR‐T</scp> cell manufacturing failure among <scp>DLBCL</scp> patients: A nationwide survey in Japan

Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama et al. · British Journal of Haematology · 2023 · 48 citations · Full text

Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival

Jakrawadee Julamanee, Seitaro Terakura, Koji Umemura et al. · Molecular Therapy · 2021 · 41 citations · Full text

Rows per page

1–5 of 14